ENDRA Life Sciences (NDRA) Other Non Operating Income (2016 - 2025)
ENDRA Life Sciences (NDRA) reported Other Non Operating Income of $42018.0 for Q3 2025, down 98.63% year-over-year from $3.1 million in Q3 2024, and up 221.58% quarter-over-quarter from $13066.0 in Q2 2025.
ENDRA Life Sciences (NDRA) Other Non Operating Income (2016 - 2025) Analysis & Trends
ENDRA Life Sciences (NDRA) has 10 years of Other Non Operating Income data on file, last reported at $42018.0 in Q3 2025.
- Other Non Operating Income for Q3 2025 came in at $42018.0, down 98.63% year-over-year; the trailing twelve-month figure through Sep 2025 was $3.1 million (down 22.91% YoY), and the FY2024 annual result was $3.1 million, up 568.14% from the prior year.
- Other Non Operating Income advanced to $42018.0 in Q3 2025 per NDRA's latest filing, from $13066.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $3.1 million in Q3 2024 and troughed at -$350145.0 in Q4 2021.
- A 5-year average of $466095.5 and a median of $18425.5 in 2022 frame the typical range for Other Non Operating Income.
- On a YoY basis, Other Non Operating Income climbed as much as 10980.93% in 2024 and fell as far as 99.61% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at -$350145.0 in 2021, then jumped by 106.79% to $23785.0 in 2022, then jumped by 3779.45% to $922726.0 in 2023, then surged by 225.62% to $3.0 million in 2024, then slumped by 98.6% to $42018.0 in 2025.
- Business Quant data shows NDRA's Other Non Operating Income at $42018.0 in Q3 2025, $13066.0 in Q2 2025, and $24390.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 42,018.00 |
| Jun 30, 2025 | 13,066.00 |
| Mar 31, 2025 | 24,390.00 |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 1,700.00 |
| Mar 31, 2024 | 4,841.00 |
| Dec 31, 2023 | 922,726.00 |
| Sep 30, 2023 | -28,226.00 |
| Jun 30, 2023 | 437,433.00 |
| Mar 31, 2023 | 3,418.00 |
| Dec 31, 2022 | 23,785.00 |
| Sep 30, 2022 | -23,011.00 |
| Dec 31, 2021 | -350,145.00 |
| Jun 30, 2021 | 1,086.00 |
| Mar 31, 2021 | 308,600.00 |
| Jun 30, 2020 | 1,265.00 |
| Mar 31, 2020 | 6,617.00 |
| Dec 31, 2019 | -51,575.00 |
| Sep 30, 2019 | -44,612.00 |